Journal article
Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality
The impact of the 13-valent pneumococcal conjugate vaccine (PCV13) at the population level is unclear. We explored PCV13\'s effect in reducing invasive pneumococcal disease (IPD)–related morbidity and mortality, and whether serotype-specific changes were attributable to vaccination or expected as a part of natural, cyclical variations.
Authors
Languages
- English
Publication year
2014
Journal
Clin Infect Dis.
Volume
8
Type
Journal article
Categories
- Vaccines & delivery devices
Countries
- Denmark
Tags
- New vaccine introduction
WHO Regions
- European Region